Treatment of symptoms of moderate to severe benign prostatic hyperplasia (BPH), Reduction of acute urinary retention and surgery risk in patients with moderate to severe BPH symptoms
Advertiser: AS “Olpha”
Information reviewed on 16.07.2024.
Prescription medicine. Complete summary of product characteristics see on www.zva.gov.lv. Information intended for healthcare specialists.